Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.

Abstract:

:Folate receptor-targeted cancer therapies constitute a promising treatment for the approximately one third of human cancers that overexpress the folate receptor (FR). However, the potencies of all folate-receptor targeted therapies depend on 1) the rate of folate-linked drug conjugate binding to the cancer cell surface, 2) the dose of folate conjugate that will saturate tumor cell surface FR in vivo, 3) the rate of FR internalization, unloading, and recycling back to the tumor cell surface for another round of conjugate uptake, and 4) the residence time of the folate conjugate before its metabolism or release from the cell. Because little information exists on any of these processes, we have undertaken to characterize them on both cancer cells in culture and solid tumors in live mice. We quantitate here the properties of FR saturation, internalization, recycling, and unloading in several cultured cancer cell lines and murine tumor models, and we describe the conditions that should maximize both the potencies and specificities of folate receptor-targeted therapies in vivo.

journal_name

Mol Pharmacol

journal_title

Molecular pharmacology

authors

Paulos CM,Reddy JA,Leamon CP,Turk MJ,Low PS

doi

10.1124/mol.104.003723

keywords:

subject

Has Abstract

pub_date

2004-12-01 00:00:00

pages

1406-14

issue

6

eissn

0026-895X

issn

1521-0111

pii

mol.104.003723

journal_volume

66

pub_type

杂志文章